Athenahealth, Inc’s (NASDAQ:ATHN) shares plunged in premarket trading session on Friday after a day the company announced 18% earnings expansion in the Q3 but still failed to meet few analysts’ forecasts.
The medical billing and records software maker reported on Thursday after markets closed that its net income for the quarter that finished Sept 30 moved up to $6.2 million or 17 cents a share, from $5.3 million or 15 cents a share in similar period previous year.
The Watertown, Massachusetts based Athenahealth reported that adjusted earnings came to 30 cents a share, which does not count items like stock-based compensation outlay.
FactSet analysts poll on average anticipated earnings of 26 cents a share.
Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Accretive Health, Inc. (NYSE:AH) rose +0.08% to settle at $12.05, Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) moved down -0.66% to end at $13.58 while The Advisory Board Company (NASDAQ:ABCO) plunged -3.35% to finish at $47.03 on Friday.
athenahealth, Inc (NASDAQ:ATHN) last session’s volume of 3.36 million shares was higher than its average volume of 417,398 shares. The stock after opening at $71.30 hit high price of $73.98 and then closed at $73.31 by scoring -8.44%.
ATHN generated revenue of $376.33 million in the previous twelve months and earned $17.19 million. The Company showed a positive 4.57% in the net profit margin as well as in its operating margin which remained at 7.89%. Company’s annual sales growth for the past five years was 34.61%.
The ATHN’s past twelve months’ price to sales ratio was 7.01 and price to cash ratio remained 16.99. As far as the returns are concerned, ATHN’s return on equity was recorded as 7.36% and return on investment increased 6.11% while its return on asset stayed at 5.25%.
The stock showed weekly downbeat performance of -10.67% which was maintained for the month at -18.21%. Likewise the negative performance for the quarter was recorded as -20.86% and for the year was 16.24% while the YTD performance remained at 49.25%.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL
